Approximately 8% of the Australian population are living with any one of about 10,000 known rare diseases.
This is similar to the proportion of people living with diabetes or asthma (rare diseases are a ‘common’ problem for clinicians).
How NextGen compares to existing tests
Over 1,278 Australian children will be born this year with a treatable genetic condition which current screening does not detect.
The existing newborn heel prick test screens for 25 genetic conditions and identifies approximately 300 affected babies per year.
The NextGen Test can identify over 50 different treatable genetic conditions, most of which are screened overseas in NZ, the USA, Germany, Singapore and Taiwan but not in Australia.
|HEEL PRICK NEWBORN SCREENING||NEXTGEN|
|Treatable conditions tested||Approx 20-25||50|
|Affected children picked up p.a.||Approx 300||Approx 1,278|
|Most common condition||CF 1/2500||FH 1/400|
|Rare conditions tested (<1/2000)||20-25||50|
The NextGen test allows you to offer your patients the most comprehensive screening currently available so that you can intervene early to prevent complications.
Our aim is to help you provide better health outcomes for your patients.
The NextGen Test for your patients
The NextGen Test has been accredited by The Royal College of Pathologists of Australasia for use in newborns, children and adults
The NextGen test is the latest in preventive health screening:
Babies & Children: Provide your patients with the latest preventive health screening for over 50 treatable conditions
Adults: Empower your patients to identify if they are a carrier of 60 serious genetic condition
Genetic testing cannot affect your patients life insurance
We work with you to provide the best quality care for your patients:
We provide pre-test counselling to make sure your patient fully understands the test
We perform testing in an accredited, state of the art genetic pathology laboratory in Sydney
We arrange (do we arrange the specialist referral appointments?) post-test counselling and specialist referrals
We provide you with the NextGen Test Report and a letter which explains everything
We’re available to answer any other questions you may have
NEXTGEN FOR BABIES
Preventative screening for babies newborn to 2 years
Screens: 20 genetic conditions
Screens: 50 genetic conditions
NEXTGEN FOR CHILDREN
Preventative screening for children 16 years & under
Screens: 40 genetic conditions
NEXTGEN FOR ADULTS
Carrier screening for adults over 16 years
Screens: 60 genetic conditions
How NextGen Test Works
You or your patient order the NextGen test online
We arrange pre-test counselling for your patient and ensure informed consent is obtained
The NextGen Test is sent to your patient
Your patient returns the mouth swab to us
We analyse the sample in our Australian labs
We arrange post-test counseling and specialist referrals for your patient
You receive a report which explains everything including the test report
We’re RCPA & NATA accredited for specialist genetic pathology testing
99.6% technical sensitivity and 100% technical specificity
We’re Australian owned and operated
Fast turn-around times
Compliance with the highest international standard for medical pathology testing (ISO15189)
Test cost includes pre and post-test counselling, delivery, testing, analysis & reports
A Medicare rebate is not currently available for the NextGen Tests
More technical information is available in a paper published in The Journal of Molecular Diagnostics